Research and analysis

ACRE advice: AIDS vaccine trial

The Advisory Committee on Releases to the Environment's advice on releasing a genetically modified human immunodeficiency virus vaccine.

• From: Advisory Committee on Releases to the Environment
• Published: 5 December 2012

Documents

Advice on an application for deliberate release of a GMO: International Aids Vaccine Initiative

PDF, 150 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document is the Advisory Committee on Releases to the Environment (ACRE’s) advice to government in considering a request from the International AIDS Vaccine Initiative to carry out a clinical trial of a genetically modified (GM) vaccine.

The committee decided that the trial would have no risk to human health or the environment, and recommended that the application should be approved.

Published 5 December 2012